Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,900
Employees9,900
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,900
Employees9,900

ELAN Key Statistics

Market cap
13.09B
Market cap13.09B
Price-Earnings ratio
-53.61
Price-Earnings ratio-53.61
Dividend yield
Dividend yield
Average volume
6.48M
Average volume6.48M
High today
$27.98
High today$27.98
Low today
$25.10
Low today$25.10
Open price
$27.37
Open price$27.37
Volume
13.87M
Volume13.87M
52 Week high
$27.98
52 Week high$27.98
52 Week low
$13.76
52 Week low$13.76

Stock Snapshot

The current Elanco(ELAN) stock price is $26.30, with a market capitalization of 13.09B. The stock trades at a price-to-earnings (P/E) ratio of -53.61.

During the trading session on 2026-08-06, Elanco(ELAN) shares reached a daily high of $27.98 and a low of $25.10. At a current price of $26.30, the stock is +4.8% higher than the low and still -6.0% under the high.

Trading activity shows a volume of 13.87M, compared to an average daily volume of 6.48M.

The stock's 52-week range extends from a low of $13.76 to a high of $27.98.

The stock's 52-week range extends from a low of $13.76 to a high of $27.98.

ELAN News

CNBC 5h
Elanco Animal Health CEO Jeff Simmons goes one-on-one with Jim Cramer - CNBC

...

Elanco Animal Health CEO Jeff Simmons goes one-on-one with Jim Cramer - CNBC
Benzinga 12h
Elanco Sees Strong Pet Health Momentum, Bets on Innovative Products

The momentum led management to raise its full-year growth outlook. The pet health company reported adjusted earnings of 34 cents, beating the consensus of 27 c...

Elanco Sees Strong Pet Health Momentum, Bets on Innovative Products
Nasdaq 15h
Elanco Animal Health Boosts FY26 Outlook; Stock Up 7% - Update

(RTTNews) - While reporting financial results for the second quarter on Wednesday, Elanco Animal Health, Inc. (ELAN) initiated its adjusted earnings and revenue...

Elanco Animal Health Boosts FY26 Outlook; Stock Up 7% - Update

Analyst ratings

89%

of 18 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

More ELAN News

TipRanks 18h
Elanco reports Q2 adjusted EPS 34c, consensus 27c

Reports Q2 revenue $1.37B, consensus $1.31B. “Elanco’s (ELAN) second quarter results demonstrate our momentum and leadership in the attractive animal health ind...

TipRanks 18h
Elanco raises FY26 adjusted EPS view to $1.10-$1.16 from $1.03-$1.09

Consensus $1.07. Raises FY26 revenue view to $5.09B-$5.14B from $5.01B-$5.09B, consensus $5.05B. Raises FY26 adjusted EBITDA view to $1.01B-$1.04B from $975M-$1...

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.